Cancer Gene Any 3 Markers NGS Test sale cost 3230 AED
LPL Expert Panel 2 Test sale cost 3280 AED LPL Expert Panel 2 Test Cost 3,640 د.إ Original price was: 3,640 د.إ.3,280 د.إCurrent price is: 3,280 د.إ.
Fibroblast Growth Factor FGF2 Test sale cost 3020 AED Fibroblast Growth Factor FGF2 Test Cost 3,350 د.إ Original price was: 3,350 د.إ.3,020 د.إCurrent price is: 3,020 د.إ.
Sale!

Cancer Gene Any 3 Markers NGS Test Cost

Original price was: 3,590 د.إ.Current price is: 3,230 د.إ.

-10%

The “Cancer Gene Any 3 Markers NGS Test” offered by DNA Labs UAE is a cutting-edge diagnostic tool designed to identify specific genetic markers associated with cancer. Utilizing Next-Generation Sequencing (NGS) technology, this test can analyze three specific genes chosen by the patient or healthcare provider to look for mutations that may indicate a higher risk of developing cancer or to understand the genetic makeup of a cancer that has already been diagnosed. This information is crucial for personalized treatment planning, as it can help in selecting targeted therapies that are more likely to be effective based on the genetic profile of the cancer.

The test is priced at 3230 AED, reflecting the advanced technology and expertise required to perform the analysis. Conducted in the state-of-the-art facilities of DNA Labs UAE, the process involves collecting a sample of blood or tissue, which is then subjected to comprehensive genomic sequencing. The results provide detailed insights into the genetic abnormalities present, aiding in early detection, prognosis, and the customization of treatment strategies.

This test represents a significant advancement in the field of oncology, offering hope for more effective management of cancer through precision medicine. By identifying specific genetic markers, patients and doctors can make informed decisions about the most appropriate and potentially effective treatment options, improving outcomes and quality of life for those affected by cancer.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CANCER GENE ANY 3 MARKERS NGS Test

At DNA Labs UAE, we offer the CANCER GENE ANY 3 MARKERS NGS Test for the diagnosis of various types of cancer. This test utilizes Next-Generation Sequencing (NGS) technology to detect specific genetic markers associated with cancer.

Test Details

Components: ANY THREE OF THE FOLLOWING: ABL1, EGFR, GNAS, KRAS, PTPN11, AKT1, ERBB2, GNAQ, MET, RB1, ALK, ERBB4, HNF1A, MLH1, RET, APC, EZH2, HRAS, MPL, SMAD4, ATM, FBXW7, IDH1, NOTCH1, SMARCB1, BRAF, FGFR1, JAK2, NPM1, SMO, CDH1, FGFR2, JAK3, NRAS, SRC, CDKN2A, FGFR3, IDH2, PDGFRA, STK11, CSF1R, FLT3, KDR, PIK3CA, TP53, CTNNB1, GNA11, KIT, PTEN, VHL

Price: 3230.0 AED

Sample Condition:

  • For Leukemias: Submit 3 mL (2 mL min.) whole blood in 1 Lavender top (EDTA) tube. Ship refrigerated. DO NOT FREEZE.
  • For Solid tumors: Submit formalin-fixed paraffin-embedded tissue block. Block should have at least 10% tumor tissue. Ship at room temperature.

Report Delivery: Sample Mon by 11 am; Report 10 Working days

Method: Next Generation Sequencing

Test Type: Cancer

Doctor: Oncologist

Test Department: MOLECULAR DIAGNOSTICS

Pre Test Information

Duly filled NGS Test Requisition Form is mandatory.

Three Cancer Gene Markers

There are many different types of cancer genes and markers that can be tested using Next-Generation Sequencing (NGS) technology. Here are three examples:

  1. BRCA1 and BRCA2: These genes are associated with an increased risk of breast and ovarian cancer. Mutations in these genes can be detected using NGS testing, which can help identify individuals who may benefit from preventive measures or targeted therapies.
  2. EGFR: This gene is commonly mutated in non-small cell lung cancer (NSCLC). NGS testing can identify specific mutations in the EGFR gene, which can guide treatment decisions, such as the use of targeted therapies like EGFR inhibitors.
  3. KRAS: Mutations in the KRAS gene are frequently found in various types of cancer, including colorectal cancer. NGS testing can detect specific mutations in the KRAS gene, which can help determine prognosis and guide treatment decisions, such as the use of targeted therapies.

It’s important to note that the specific genes and markers tested may vary depending on the type of cancer being investigated and the specific NGS panel being used.

Test Name CANCER GENE ANY 3 MARKERS NGS Test
Components ANY THREE OF THE FOLLOWING: ABL1, EGFR, GNAS, KRAS, PTPN11, AKT1, ERBB2, GNAQ, MET, RB1, ALK, ERBB4, HNF1A, MLH1, RET, APC, EZH2, HRAS, MPL, SMAD4, ATM, FBXW7, IDH1, NOTCH1, SMARCB1, BRAF, FGFR1, JAK2, NPM1, SMO, CDH1, FGFR2, JAK3, NRAS, SRC, CDKN2A, FGFR3, IDH2, PDGFRA, STK11, CSF1R, FLT3, KDR, PIK3CA, TP53, CTNNB1, GNA11, KIT, PTEN, VHL
Price 3230.0 AED
Sample Condition For Leukemias: Submit 3 mL (2 mL min.) whole blood in 1 Lavender top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. For Solid tumors : Submit formalin fixed paraffin embedded tissue block. Block should have at least 10% tumor tissue.Ship at room temperature. \nDuly filled NGS Test Requisition Formis mandatory.
Report Delivery Sample Mon by 11 am; Report 10 Working days
Method Next Generation Sequencing
Test type Cancer
Doctor Oncologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information Duly filled NGS Test Requisition Formis mandatory.
Test Details

There are many different types of cancer genes and markers that can be tested using Next-Generation Sequencing (NGS) technology. Here are three examples:

1. BRCA1 and BRCA2: These genes are associated with an increased risk of breast and ovarian cancer. Mutations in these genes can be detected using NGS testing, which can help identify individuals who may benefit from preventive measures or targeted therapies.

2. EGFR: This gene is commonly mutated in non-small cell lung cancer (NSCLC). NGS testing can identify specific mutations in the EGFR gene, which can guide treatment decisions, such as the use of targeted therapies like EGFR inhibitors.

3. KRAS: Mutations in the KRAS gene are frequently found in various types of cancer, including colorectal cancer. NGS testing can detect specific mutations in the KRAS gene, which can help determine prognosis and guide treatment decisions, such as the use of targeted therapies.

It’s important to note that the specific genes and markers tested may vary depending on the type of cancer being investigated and the specific NGS panel being used.

SKU: TEST-4767 Category:

Related products